A GP guide to deprescribing antipsychotics

How to safely withdraw antipsychotics prescribed for the treatment of behavioural and psychological symptoms of dementia

The Royal Commission into Aged Care Quality and Safety Interim Report, released on 31 October 2019, identified a need to respond to the significant overreliance on chemical restraint in aged care.1

In response to this, the Australian Government announced their plan to establish stronger safeguards and restrictions on repeat prescriptions of risperidone for the treatment of behavioural and psychological symptoms of dementia (BPSD) of the Alzheimer type.2 These took effect on 1 January 2020.3